Covered recipient · General Payments record
ELLIS J NEUFELD
Allopathic & Osteopathic Physicians Pediatrics Pediatric Hematology-Oncology
General Payments · PY2018–2024
$322,031.42
- Reported across 153 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $40,752.47 | 12 |
| Honoraria | $2,750.00 | 1 |
| Travel and Lodging | $904.47 | 2 |
| Food and Beverage | $463.99 | 4 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $21,042.97 | 10 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13,249.50 | 1 |
| Genentech USA, Inc. | $7,828.46 | 7 |
| HEMA Biologics, LLC | $2,750.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Genentech USA, Inc. | $170.20 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133006914 | CMS |
| Genentech USA, Inc. | $115.60 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133006918 | CMS |
| Genentech USA, Inc. | $664.30 | 09/06/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1133006922 | CMS |
| Genentech USA, Inc. | $25.76 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133006926 | CMS |
| Genentech USA, Inc. | $152.43 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133006930 | CMS |
| Genentech USA, Inc. | $6,460.00 | 09/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133006934 | CMS |
| Genentech USA, Inc. | $240.17 | 09/06/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1133006938 | CMS |
| HEMA Biologics, LLC | $2,750.00 | 01/24/2024 | Honoraria | Undisputed | 01/23/2026 | 1152820865 | CMS |
| Merck Sharp & Dohme LLC | $2,257.00 | 01/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141623723 | CMS |
| Merck Sharp & Dohme LLC | $2,013.00 | 03/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141843361 | CMS |
| Merck Sharp & Dohme LLC | $1,220.00 | 04/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141623711 | CMS |
| Merck Sharp & Dohme LLC | $2,541.67 | 04/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141843359 | CMS |
| Merck Sharp & Dohme LLC | $1,677.50 | 05/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141623713 | CMS |
| Merck Sharp & Dohme LLC | $1,268.80 | 05/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141623719 | CMS |
| Merck Sharp & Dohme LLC | $2,897.50 | 10/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141623717 | CMS |
| Merck Sharp & Dohme LLC | $2,287.50 | 10/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141623715 | CMS |
| Merck Sharp & Dohme LLC | $2,135.00 | 11/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141623721 | CMS |
| Merck Sharp & Dohme LLC | $2,745.00 | 12/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141623627 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13,249.50 | 10/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1137642810 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.